PSUSA/00009084/201812 - periodic safety update report single assessment
Botulinum neurotoxin type a (150 kd) free from complexing proteins
PSUSA
Human
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Botulinum neurotoxin type a (150 kD) free from complexing proteins: List of nationally authorised medicinal products - PSUSA/00009084/201812
English (EN) (262.02 KB - PDF)
Botulinum neurotoxin type a (150 kD) free from complexing proteins: CMDh Scientific conclusions, amendments to product information and implementation timetable - PSUSA/00009084/201812
English (EN) (27.22 KB - PDF)
български (BG) (123.89 KB - PDF)
español (ES) (172.84 KB - PDF)
čeština (CS) (103.57 KB - PDF)
dansk (DA) (67.71 KB - PDF)
Deutsch (DE) (161.59 KB - PDF)
eesti keel (ET) (164.51 KB - PDF)
ελληνικά (EL) (192.3 KB - PDF)
français (FR) (152.3 KB - PDF)
hrvatski (HR) (122.2 KB - PDF)
íslenska (IS) (148.52 KB - PDF)
italiano (IT) (104.25 KB - PDF)
latviešu valoda (LV) (192.51 KB - PDF)
lietuvių kalba (LT) (203.76 KB - PDF)
magyar (HU) (231.7 KB - PDF)
Malti (MT) (51.91 KB - PDF)
Nederlands (NL) (107.72 KB - PDF)
norsk (NO) (27.43 KB - PDF)
polski (PL) (201.15 KB - PDF)
português (PT) (28.11 KB - PDF)
română (RO) (216.06 KB - PDF)
slovenčina (SK) (240.42 KB - PDF)
slovenščina (SL) (97.38 KB - PDF)
Suomi (FI) (95.67 KB - PDF)
svenska (SV) (98.65 KB - PDF)